Toxoplasmosis during pregnancy and infancy a new approach for Switzerland Swiss Working Group on congenital Toxoplasmosis

Swiss Medical Weekly

Volumn 138, Issue 49-50 SUPPL. 168, 2008, Pages 1-8

  Rudin, C ^b   Boubaker, K ^a   Raeber, P A ^b   Vaudanx, B ^b   Bucher, H C ^b   Garweg, J G ^b   Hoesli, I ^b   Kind, C ^b   Hohlfeld, R ^b  

^a FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FANSIDAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SPIRAMYCIN;

AMNIOCENTESIS; AUSTRIA; CHORIORETINITIS; CLINICAL FEATURE; CONGENITAL TOXOPLASMOSIS; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG EFFECT; FRANCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFANCY; MORBIDITY; MULTIPLE CYCLE TREATMENT; PREGNANCY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PROPHYLAXIS; REVIEW; RISK FACTOR; SEROCONVERSION; SEROPREVALENCE; SWITZERLAND; TOXOPLASMA GONDII;

EID: 58149291288     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Schweizerische Medizinische Wochenschrift 1995;125(Suppl. 65):3S-120S.
2. Kind C and Swiss Paediatric Surveillance Unit. Symptomatische konnatale Toxoplasmose: Häufigkeit in der Schweiz 1995-1996 (abstr). Schweiz Med Wochenschr. 1996;126(suppl 87):5S.
3. Frenkel JK. Toxoplasmosis. Pediatr Clin North Am. 1985;32:917-932.
4. Jacquier P, Hohlfeld P, Vorkauf H, Zuber P. Epidemiology of toxoplasmosis in Switzerland: national study of seroprevalence monitored in pregnant women 1990-1991. Schweiz Med Wochenschr. 1995;65(Suppl.):29S-38S.
5. Signorell LM, Seitz D, Merkel S, Berger R, Rudin C. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland 1982-1999. Paediatr Infect Dis J. 2006;25(2):123-8.
6. Vaudaux B. personal communication
7. Sagmeister M, Gessner U, Kind C, Horisberger B. Kosten-Nutzen-Analyse des Screenings auf kongenitale Toxoplasmose. Schweiz Med Wochenschr. 1995;Suppl. 65:103S-12S.
8. Desmonts G, Couvreur J. Congenital toxoplasmosis. N Engl J Med. 1974;290:1110-6.
9. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, et al. Foetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989;115:765-9.
10. Mittendorf R, Pryde P, Herschel M, Williams MA. Is routine antenatal toxoplasmosis screening justified in the United States? Statistical considerations in the application of medical screening tests. Clin Obstet Gynecol. 1999;42(1):163-75.
11. Foulon W, Naessens A, Derede M. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol. 1994;11(1):57-62.
12. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counseling. Lancet. 1999;353:1829-33.
13. Douche C, Benabdesselam A, Mokhtari F, Le Mer Y. Value of prevention of congenital toxoplasmosis. J Fr Ophtalmol. 1996;19:330-4.
14. Knerer B, Hayde M, Gratz G, Bernaschek G, Strobl W, Pollak A. Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of foetal toxoplasma infection. Wien Klin Wochenschr. 1995;107:137-40.
15. Excler JL, Piens MA, Maisonneuve H, Pujol E, Garin JP. Dépistage de la toxoplasmose acquise chez la femme enceinte et de la toxoplasmose congénitale chez le nouveau-né. Lyon Med. 1985;253:33-8.
16. Desmonts G, Couvreur J. Toxoplasmose congénitale. Ann de Pediatr. (Paris) 1984;31:805-9.
17. Roux C, Desmonts G, Mulliez N, Gaulier M, Tufferaud G, Marmor D, et al. Toxoplasmosis and pregnancy. Evaluation of 2 years of prevention of congenital toxoplasmosis in the maternity ward of Hôpital Saint-Antoine (1973-1974). J Gynecol Obstet Biol Reprod. (Paris) 1976;5:249-64.
18. Lambotte R, Bassleer J, Beaudouin PH, Senterre J, Lhoist R. Toxoplasmose congénitale: évaluation du bénéfice thérapeutique prénatal. J Gynecol Obstet Biol Reprod. (Paris) 1976;5:265-9.
19. Thoumsin H, Senterre J, Lambotte R. Twenty-two years of screening for toxoplasmosis in pregnancy: Liege-Belgium. Scand J Infect Dis. 1992;84(suppl):84-5.
20. Kräubig H. Präventive Behandlung der konnatalen Toxoplasmose. In: Kirchhoff H, Kräubig H, eds. Toxoplasmose. Praktische Fragen und Ergebnisse. Stuttgart: Georg Thieme Verlag, 1966.
21. Wallon M, Peyron F, Lebech M, Petersen E, Gilbert R, Dunn D. Prenatal treatment and the risk of congenital toxoplasmosis: preliminary findings from two cohort studies [abstract No 94.] European Society for Research in Paediatrics annual meeting, Szedeg, Hungary 1997. Pediatr Res. 1997;42:400.
22. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ. 1999;318:1511-4.
23. Peyron F, Wallon M, Liou C, Garner P. Cochrane Database Syst Rev. 2000;(2):CD001684.
24. Pratlong F, Boulot P, Villena I, Issert E, Tamby I, Cazenave J, Dedet JP. Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br J Obstet Gynaecol. 1996;103(6):552-7.
25. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994;331(11):695-9.
26. Guerina N, Hsu H, Meissner C, Maguire J, Lynfield R. Stechenberg B, et al. Neonatal serologic screening and early treatment of congenital Toxoplasma gondii infection. N Engl J Med. 1994;330(26):1858-63.
27. http://eurotoxo.isped.u-bordeaux2.fr
28. Antenatal care: routine care for the healthy pregnant woman, NICE, October 2003: http://www.nice.org.uk/pdf/CG6ANCNICEguideline.pdf
29. Bénard A, Petersen E, Salamon R, et al. Euro Surveill. 2008;13(18).
30. Peyron F, Wallon M, Liou C, Garner P. Cochrane Database of Systematic Review 1999; Issue 3.
31. Martinelli P, Agnagni A, Maruotti GM. Screening for toxoplasmosis in pregnancy. Lancet. 2007;369:823-4.
32. Khosnhnood B, de Vigan K., Goffinet E, Leroy V (2007): Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening. Prenatal diagnosis March 22 (Epub ahead of print)
33. Bader TJ, Macones GA, Asch DA. Prenatal screening for toxoplasmosis. Obstet Gynecol. 1997;90:457-64.
34. Lebech M, Andersen O, et al. "Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group." Lancet. 1999;353(9167):1834-7.
35. Gilbert RE, Thalib L, Tan HK, et al. for the European Multicentre Study on Congenital Toxoplasmosis (EMSCOT) 2007;14:8-13.
36. Silveira C, Belfort RJR, Muccioli C, Holland GN, Victora CG, Horta BL, Fei Yu, Nussenblatt RB. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthal. 2002;134(1):41-6.
37. Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius, Petersen E. The National Neonatal Screening Program for Congenital Toxoplasmosis in Denmark: a result from the initial four years, 1999-2002. Arch Dis Child. 2006;91:661-5.